Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Consulting agrmnt
Director departure
Appointed director
|
|
ORAMED PHARMACEUTICALS INC. (ORMP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/10/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/15/2022 |
4/A
| RAKIN KEVIN (Director) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Gifted 5,000 shares
@ $0 |
|
| 01/11/2022 |
4/A
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 150,000 shares
@ $0
Paid exercise price by delivering 48,752 shares
@ $13.89, valued at
$677.2k
Granted 63,000 shares
@ $0
Granted 107,000 options to buy
@ $13.89, valued at
$1.5M
|
|
| 12/07/2021 |
4/A
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Sold 220,000 shares
@ $20.1052, valued at
$4.4M
|
|
| 12/07/2021 |
4/A
| KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 10/05/2011 |
4/A
| Bronfeld Zeev (10% Owner) has filed a Form 4 on ORAMED PHARMACEUTICALS INC. |
|
|